Decursin
Cat.No:ID2400 Solarbio
CAS:5928-25-6
Molecular Formula:C19H20O5
Molecular Weight:328.36
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
TGF-β/Smad >
DecursinCAS:5928-25-6
Molecular Formula:C19H20O5
Molecular Weight:328.36
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 5928-25-6 |
Name | Decursin |
Molecular Formula | C19H20O5 |
Molecular Weight | 328.36 |
Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
Purity | HPLC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00272154 |
SMILES | C/C(C)=C\C(O[C@H](C(C)(C)O1)CC2=C1C=C(O3)C(C=CC3=O)=C2)=O |
Target Point | PKC |
Passage | TGF-beta/Smad;Epigenetics |
Background | Decursin is a potent protein kinase C (PKC) activator. |
Biological Activity | Decursin 是一种抗癌物质,并具有潜在的抗炎活性。[1-2] |
Data Literature Source | [1]. Yim D,et al. A novel anticancer agent,decursin,induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005 Feb 1;65(3):1035-44. [2]. Shehzad A,et al. Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases. Inflamm Res. 2018 Mar;67(3):209-218 |
Unit | Bottle |
Specification | 5mg 10mg 20mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.